免疫细胞表型的门德尔随机化,以发现B细胞恶性瘤的潜在药物标
Sina A Beer1, Molly Went2, Charlie Mills2
1Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. sina.beer@icr.ac.uk.
Blood cancer journal
|April 8, 2025
概括
门德尔随机化确定了24个B细胞恶性瘤的可药物治疗的细胞表面标,包括BAFF-R和CD39.9等新型候选者. 这种基因方法有助于发现难以治疗的癌症的新治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 尽管取得了进展,但B细胞恶性瘤的治疗响应率仍然有限.
- 在B细胞癌症中,急需新的治疗点.
研究的目的:
- 用遗传方法识别和优先考虑六种B细胞恶性瘤的潜在药物标.
- 利用门德尔随机化来探索免疫特征和B细胞癌症之间的因果关系.
主要方法:
- 孟德尔随机分析了445种免疫细胞特征,用于预防毛囊淋巴瘤,DLBCL,霍奇金淋巴瘤,MZL,CLL和多发性骨髓瘤.
- 将遗传发现与观察数据和临床试验证据相结合.
- 药用细胞表面标记物的识别.
主要成果:
- 163个免疫特征与至少一个B细胞恶性瘤有暗示性关联 (P <0.05);34个在多次测试校正后显著 (P <2x10^-4).
- 24种可药物治疗的细胞表面标记物被确定为潜在的治疗点.
- 突出的新目标包括BAFF-R,CD39,CD25,CD27,CD80/86和CCR2,以及已经确定的目标,如CD3,CD20和CD38.
结论:
- 人类遗传学可以有效地指导发现B细胞恶性瘤的药物标.
- 确定的目标为开发新疗法提供了有希望的途径,以改善患者的治疗结果.
更多相关视频
08:22Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
Published on: May 31, 2020
5.0K
09:25Detection and Enrichment of Rare Antigen-specific B Cells for Analysis of Phenotype and Function
Published on: February 16, 2017
11.4K
相关概念视频
01:24B Cell Activation and Differentiation
1.3K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.3K
01:28Diversity of Antigen Receptors
393
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
393